Fredun Pharmaceuticals Limited (BOM:539730)
India · Delayed Price · Currency is INR | Market Cap | 5.88B |
| Revenue (ttm) | 4.97B |
| Net Income (ttm) | 223.75M |
| Shares Out | 4.70M |
| EPS (ttm) | 50.75 |
| PE Ratio | 24.66 |
| Forward PE | n/a |
| Dividend | 0.70 (0.05%) |
| Ex-Dividend Date | Sep 23, 2025 |
| Volume | 6,703 |
| Average Volume | 22,151 |
| Open | 1,324.00 |
| Previous Close | 1,325.30 |
| Day's Range | 1,261.00 - 1,324.00 |
| 52-Week Range | 635.00 - 1,329.00 |
| Beta | 0.86 |
| RSI | 66.94 |
| Earnings Date | Nov 7, 2025 |
About Fredun Pharmaceuticals
Fredun Pharmaceuticals Limited manufactures and sells pharmaceutical formulations, dietary/herbal supplements, nutraceuticals, and other healthcare products in India, Africa, Southeast Asia, CIS countries, and Latin America. The company offers allopathic formulations, including analgesics/NSAID, antacid/antiulcer, anthelmintic, anti-bacterial, anti-diabetic, anti-inflammatory, anti-malarial, anti-obesity, antacid, anthelmintic, antibacterial, analgesics, anti-diabetic, anti-inflammatory, anti-malarial, anti-obesity, anticoagulants, anticonvulsa... [Read more]
Financial Performance
In 2024, Fredun Pharmaceuticals's revenue was 4.56 billion, an increase of 31.05% compared to the previous year's 3.48 billion. Earnings were 197.39 million, an increase of 26.34%.
Financial StatementsNews
Fredun Pharmaceuticals stock jumps 3% after company set to launch advanced functional foods plant
Fredun Pharmaceuticals Limited saw a 3% jump in its stock price following the announcement of its new cutting-edge functional foods manufacturing facility. Located in Palghar, Maharashtra, this state-...